Collaborators and Affiliates
AlaBioPharma engages with biotechs, mid-cap pharmaceuticals, foundations, and investment teams. We accept a small number of new engagements each year, and we are direct about whether the fit is right.

-
Wellcome Foundation/NC3Rs
-
Lean Sigma
-
GLG
-
American Society for Pharmacology and Experimental Therapeutics
-
International Union of Pharmacology
-
European College of Pharmacology
-
Society for Neuroscience
-
British Pharmacological Association
-
Safety Pharmacology Society
-
American College on Toxicology
-
College on Problems of Drug Dependence
-
Rosiland Franklin Medical College
-
World Anti-Doping Agency
Emerging Biotech
Venture-backed sponsors approaching first-in-human
​
Pre-IND through Phase 1 strategy. We act as fractional senior pharmacology or regulatory lead, available to investors and the board, embedded in the science of the program.
Mid- and Large-Cap Pharmaceuticals
Internal program reviews and second opinions
​
Independent senior counsel for internal go / no-go decisions, abuse-liability strategy, and CNS-specific program reviews. Engagements are usually scoped around a single decision point.
-
Cross-Company Abuse Liability Counsil
-
University of Edenborough, Dept. of Engineering
-
University of Illinois
-
University of Indiana
-
McLean Hospital ​​
-
National Institutes of Health
Investors and Boards
Independent scientific diligence engagements for venture, growth, and corporate development teams. We read the data, identify the questions the deck does not answer, and put our name on the memo.
Foundations and Academics
Standing scientific advisor and grant-review support for disease foundations and academic translational programs. Reduced rate structure for non-commercial work.

We Welcome Partnerships
ALA+ BioPharma is Consulting, Discovery, Development, Ventures, Partnerships
Medicines for People. Everyone is People.